Clinical Trial Update: 28 Day Repeat Dose in Cystic Fibrosis Patients [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 trial evaluating a 28-day repeat-dose regimen in cystic fibrosis patients and indicates that results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17